Nasdaq: DYN
Dyne Therapeutics insiders
The officers, directors and 10% owners of Dyne Therapeutics, Inc. who hold the most stock, valued at the live DYN price.
$16.03
DYN today +$160K (+1.01%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 5
- Their DYN stock
- $208M
- Market value
- $3.00B
- Held by ranked insiders
- 6.93%
Insiders by value of DYN holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Atlas Venture Associates XI, LLC | 10% owner | 6,352,562 | $102M | 3.39% | Corporate |
| 2 | Atlas Venture Associates XI, L.P. | 10% owner | 5,698,091 | $91.3M | 3.04% | Corporate |
| 3 | Joshua T. Brumm | CEO & President | 537,998 | $8.6M | 0.29% | 7600th |
| 4 | John Cox | CEO & President | 369,994 | $5.9M | 0.20% | 12878th |
| 5 | Brian S. Posner | Director | 27,000 | $433K | <0.1% | 6223rd |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Dyne Therapeutics; see each profile for the filing.